Method for preparing induced pluripotent stem cells as well as composition used in method and application of composition
A technology of pluripotent stem cells and compositions, applied in the field of preparation of induced pluripotent stem cells, which can solve problems such as inability to obtain chimera mice
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0058] Preparation method of I.iPSC
[0059] overview
[0060] In general, the present invention provides a method for preparing iPSCs using a composition containing a c-Jun antagonist and a composition containing a c-Jun antagonist for promoting the formation of induced pluripotent stem cells (iPSCs) used in the method, the The composition comprises a c-Jun antagonist, such as a c-Jun antagonist having a bZIP domain but lacking a transactivation domain, antagonizing A compound, antibody or antibody fragment that is c-Jun active.
[0061] In one aspect, the present invention provides a method for preparing induced pluripotent stem cells (iPSCs), the method comprising introducing a composition promoting the formation of induced pluripotent stem cells (iPSCs) into somatic cells, wherein the composition comprises:
[0062] (i) c-Jun antagonist, and a group of factors selected from the following seven groups of factors: (1) Sox2, Klf4 and c-Myc, (2) Klf4 and c-Myc, (3) Oct3 / ...
Embodiment 1
[0258] Example 1. Inhibitory effect of c-Jun on somatic cell reprogramming
[0259] (1) c-Jun plays different roles in somatic cells and stem cells
[0260] In order to study the role of c-Jun in somatic cells and stem cells, mouse embryonic stem cells and mouse embryonic fibroblasts were selected as models, and TRIzol was used to extract the total mRNA in mouse embryonic stem cells and mouse embryonic fibroblasts, Subsequently, qPCR was performed by the procedure described below: cDNA was prepared with ReverTra Ace (Toyobo) and oligo-dT, followed by qPCR (Takara) analysis with Premix Ex Taq.
[0261] Figure 1A The expression levels of c-Jun in mouse embryonic stem cells, induced pluripotent stem cells and mouse embryonic fibroblasts are compared with Oct4 and Nanong. Such as Figure 1AAs shown, the expression of c-Jun is lower in mouse embryonic stem cells and induced pluripotent stem cells, but higher in mouse embryonic fibroblasts.
[0262] In order to further verify t...
Embodiment 2
[0325] Example 2. Role of the bZIP domain in c-Jun
[0326] 1. Effects of c-Jun domains on somatic cell reprogramming
[0327] The JNK-phosphorylation site (Ser63 / Ser73) mutant of c-Jun and the truncated c-Jun located at amino acid 170 to amino acid 334 with a bZIP domain but lacking a transactivation domain were constructed by molecular cloning methods. Jun (c-JunDN). The amino acid sequence of wild-type c-JunWT is the following SEQ ID NO.1; the amino acid sequence of c-JunDN is SEQ ID NO.2.
[0328] Amino acid sequence (SEQ ID NO.1) of wild-type c-JunWT (ie, full-length c-Jun):
[0329] mtakmettfy ddalnasflq sesgaygysn pkilkqsmtl nladpvgslk phlraknsdl 60
[0330] ltspdvgllk laspelerli iqssnghitt tptptqflcp knvtdeqegf aegfvralae 120
[0331] lhsqntlpsv tsaaqpvsga gmvapavasv agaggggggys aslhseppvy anlsnfnpga 180
[0332] lssgggapsy gaaglafpsq pqqqqqppqp phhlpqqipv qhprlqalke epqtvpempg 240
[0333] etpplspidm esqerikaer krmrnriaas kcrkrkleri arleekvktl kaqnselast 300 ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com